About: Hydrocortisone Sodium Succinate     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:label
  • Hydrocortisone Sodium Succinate
rdfs:subClassOf
Concept_In_Subset
Semantic_Type
  • Pharmacologic Substance
  • Steroid
Preferred_Name
  • Hydrocortisone Sodium Succinate
NSC_Code
  • 9152
UMLS_CUI
  • C0770560
CAS_Registry
  • 125-04-2
FDA_UNII_Code
  • 50LQB69S1Z
Contributing_Source
  • FDA
PDQ_Open_Trial_Search_ID
  • 39861
PDQ_Closed_Trial_Search_ID
  • 39861
Chemical_Formula
  • C25H33O8.Na
Legacy_Concept_Name
  • Hydrocortisone_Sodium_Succinate
FULL_SYN
  • FlebocortidSYDTPNSC0009152
  • Emergent-EZBRNCI
  • A-HydrocortBRNCI
  • Solu-CortefBRNCI
  • FlebocortidFBNCI
  • (11beta)-21-(3-Carboxy-1-oxopropyl)-11,17-dihydroxypregn-4-ene-3,20-dione, Monosodium SaltPTDCP06055
  • Hidroc CloraFBNCI
  • Hydrocortisone 21-Sodium SuccinateSYNCI
  • Hydro-AdresonFBNCI
  • Hydro-adresonSYDTPNSC0010483
  • (11beta)-21-(3-Carboxy-1-oxopropyl)-11,17-dihydroxypregn-4-ene-3,20-dione, Monosodium SaltSNNCI
  • CorlanSYDTPNSC0009152
  • Cortisol Sodium SuccinateSYNCI
  • HYDROCORTISONE SODIUM SUCCINATEPTFDA50LQB69S1Z
  • Hydrocortisone Na SuccinateSYNCI
  • HycoraceSYDTPNSC0009152
  • CorlanFBNCI
  • CortopFBNCI
  • Solu-GlycSYDTPNSC0009152
  • KinogenFBNCI
  • NordicortSYDTPNSC0009152
  • HycoraceSYNCI
  • NositrolFBNCI
  • BuccalsoneSYDTPNSC0009152
  • Sodium hydrocortisone succinateSYDTPNSC0009152
  • Hydrocortisone sodium succinateSYDTPNSC0009152
  • Solu-GlycFBNCI
  • NordicortFBNCI
  • HydrocortFBNCI
  • Hydrocortisone Sodium SuccinatePTNCI
  • Cortisol sodium succinateSYDTPNSC0009152
  • Solu-CortefSYDTPNSC0009152
  • BuccalsoneFBNCI
  • EfcortelanFBNCI
  • SinsurreneFBNCI
DEFINITION
  • The sodium salt of hydrocortisone succinate with glucocorticoid property. Hydrocortisone sodium succinate is chemically similar to the endogenous hormone that stimulates anti-inflammatory and immunosuppressive activities, in addition to exhibiting minor mineralocorticoid effects. This agent binds to intracellular glucocorticoid receptors and is translocated into the nucleus, where it initiates the transcription of glucocorticoid-responsive genes, such as various cytokines and lipocortins. Lipocortins inhibit phospholipase A2, thereby blocking the release of arachidonic acid from membrane phospholipids and preventing the synthesis of prostaglandins and leukotrienes, both potent mediators of inflammation.NCI
code
  • C1819
sameAs
http://linked.open...y/mesh/hasConcept
is sameAs of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 46 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software